Human Reproduction, Vol. 15, No. 10, 2093-2097,
October 2000
© 2000 European Society of Human Reproduction and Embryology
Prospective randomized trial to evaluate the efficacy of a vaginal ring releasing progesterone for IVF and oocyte donation
1 Unidad de Medicina Reproductiva, Clínica Las Condes, Santiago, 2 Laboratorios Silesia, Santiago, Chile, 3 Unidad de Fertilidad del Country, Bogota, Colombia and 4 FERTILITY – Centro de Fertilización Asistida, Sao Paulo, Brazil
A polysyloxane vaginal ring containing 1g of natural progesterone was developed as luteal supplementation for women treated with IVF–embryo transfer and for agonadal women participating in an oocyte donation programme. The ring provides continuous release of progesterone (10-20 nmol/l) for 90 days. The efficacy of this form of progesterone supplementation was evaluated in two multicentre prospective randomized trials. IVF–embryo transfer trial: After oocyte aspiration, 505 women were randomly allocated to progesterone supplementation with vaginal ring or i.m. progesterone (50 mg/day). The clinical pregnancy rate was 36.6% in both groups. Implantation rate was 15.9% in the vaginal ring and 16.0% in i.m. progesterone. Oocyte donation trial: After endometrial proliferation with micronized oestradiol, 153 women were allocated to progesterone replacement with a vaginal ring or i.m. progesterone (100 mg/day). Clinical pregnancy rate was 39.8 and 28.6% respectively. Implantation rate was significantly higher with the vaginal ring compared with i.m. progesterone (19.9 and 11.6% respectively, P = 0.006). The vaginal ring is a novel development which provides continuous release of progesterone for 90 days. In IVF–embryo transfer, its effectiveness is similar to daily i.m. injections. In oocyte donation the ring provides a progestative milieu which improves the implantation rate and eliminates the discomfort of daily i.m. injections.
Key words: IVF/oocyte donation/progesterone supplementation/vaginal ring
5 To whom correspondence should be addressed at: Unidad de Medicina Reproductiva, Clínica Las Condes, Santiago, Chile. E-mail: umrclc{at}entelchile.net
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  F. Nawroth and M. Ludwig What is the 'ideal' duration of progesterone supplementation before the transfer of cryopreserved-thawed embryos in estrogen/progesterone replacement protocols? Hum. Reprod., May 1, 2005; 20(5): 1127 - 1134. [Abstract] [Full Text] [PDF]
|
|